IMMUNOTECH LABORATORIES, INC.

Highlights Immunotech Laboratories, Inc.

Equities

IMMB

US45254F2039

Market Closed - OTC Markets Other stock markets 18:01:22 18/03/2024 GMT			5-day change	1st Jan Change
0.0001 ^USD	-.--%		-.--%	-.--%

2017	Immunotech Laboratories, Inc. Announces Addition of Hongxiang Hui to Advisory Board	CI
2017	Immunotech Laboratories Enters Distribution Agreement for the Territory of the Ukraine; Enters Final Step of Full Commercialization by the BDA Post Phase 3 Approval of ITV-1 for HIV/AIDS	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Immunotech Laboratories Enters Distribution Agreement for the Territory of the Ukraine; Enters Final Step of Full Commercialization by the BDA Post Phase 3 Approval of ITV-1 for HIV/AIDS	22/06/17	CI
Eco-Petroleum Solutions, Inc. acquired Immunotech Laboratories, Inc..	13/06/17	CI
Immunotech Laboratories, Inc. and Immunotech Laboratories, BG Enter into Agreement with Uldic Investment to Market Potential Ebola Virus Disease Treatment in Africa	21/10/14	CI
Immunotech Laboratories, Inc and Immunotech Laboratories, BG. Announces Successful Completion of Phase I and Phase II Field Trials of HIV/AIDS and Hepatitis C Virus Treatment	07/10/14	CI
Immunotech Laboratories, Inc. Announces Completion of Phase I and Phase II Field Trials of Patented Treatment of the HIV/AIDS and Hepatitis C Viruses	28/08/14	CI
Immunotech Laboratories, Inc. Relocates to New Research & Development Laboratory Facility	01/03/13	CI
Immunotech Laboratories, Inc. Announces Clinical Trials Updates for company's AIDS-HIV 'IPF' Medicines	20/02/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW